[The change of intestinal mucosa barrier in chronic severe hepatitis B patients and clinical intervention].
Author(s): Song HY, Jiang CH, Yang JR, Chen QH, Huang J, Huang YH, Liang LX
Affiliation(s): Deparment of Gastroenterology, the People Hospital of Guangxi Zhuangzu Autonomous Region, Nanning 530021, China.
Publication date & source: 2009-10, Zhonghua Gan Zang Bing Za Zhi., 17(10):754-8.
Publication type: English Abstract; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
OBJECTIVE: To study the change of intestinal mucosa barrier in chronic severe hepatitis B patients and clinical intervention. METHOD: (1) 30 normal healthy controls and 60 chronic severe hepatitis B patients were enrolled in this study. The change of intestinal permeability was determined by urine lactulose/ mannitol ratio (L/M), and the serum diamine oxidase (DAO) was measured. (2) 60 chronic severe hepatitis B patients were randomly divided into two groups: the control group and the treated group, each group has 30 cases. Patients in the control group received standard treatment for 2 weeks, however, in addition to standard treatment, patients in the treated group also received glutamine 10g tid. Endotoxin (ET), DAO and L/M were compared between the two group. RESULTS: (1) Compared to healthy controls, the level of L/M and DAO was significantly increased in chronic severe hepatitis B patients (t = 2.762, P less than 0.01 or t = 6.326, P less than 0.01). (2) Compared to the control group, ET, DAO and L/M were significantly lower 2 weeks after treatment (F = 11.662, P less than 0.01; F = 12.699, P less than 0.01; F = 19.981, P less than 0.01). CONCLUSION: (1) There is an early intestinal mucosa barrier damage in chronic severe hepatitis B patients. (2) Compared to standard treatment, adding glutamine can reverse intestinal mucosa barrier damage.